GLP-1 receptor agonists are already widely used for diabetes and obesity management, and their use has increased rapidly in recent years
Similarly, obesity management requires evidence-based approaches
Knowing where Brello sits relative to those alternatives is key to making the right decision
This article explains the key differences between traditional and bioidentical hormone therapy, including how they work, their benefits, risks, and customization options, to help you make an informed, personalized decision with your healthcare provider
While traditional approaches have focused on amyloid (A) plaques and tau pathology, emerging evidence highlights the role of metabolic dysfunction, mitochondrial impairment, and hormonal signaling in the pathogenesis of AD